Cholesteatoma-associated pathogenicity: Potential role of lysosomal exoglycosidases

Otology and Neurotology

Volumn 33, Issue 4, 2012, Pages 596-603

  Olszewska, Ewa ^a   Jakimowicz Rudy, Joanna ^b   Knas, Malgorzata ^a   Chilimoniuk, Malgorzata ^c   Pietruski, Jan Krzysztof ^d   Sieskiewicz, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Pharmacology ^*  (Poland)

^c Marie Sklodowskiej Curie Oncology Center   (Poland)

^d Dental Practice in Bialystok   (Poland)

Author keywords

galactosidase; glucuronidase; Cholesteatoma; N acetyl hexosaminidase; Retroauricular skin; Serum

Indexed keywords

BETA GALACTOSIDASE; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE;

ADULT; ARTICLE; BLOOD; CHOLESTEATOMA; ENZYMOLOGY; HUMAN; LYSOSOME; MIDDLE AGED; SKIN;

ADULT; BETA-GALACTOSIDASE; BETA-N-ACETYLHEXOSAMINIDASES; CHOLESTEATOMA, MIDDLE EAR; GLUCURONIDASE; HUMANS; LYSOSOMES; MIDDLE AGED; SKIN;

EID: 84861316191     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31824bae8d     Document Type: Article

References (34)

1. Kemppainen HO, Puhakka HJ, Laippala PJ, Sipila MM, Manninen MP, Karma PH. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolarygol (Stockh) 1999;119:568-72.
2. Broekaert D, Coucke P, Leperque S, et al. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 1992;101: 931-8.
3. Ferlito A. Clinicopathological consultation ear cholesteatoma versus cholesterol granuloma. Ann Otol Rhinol Laryngol 1997;106: 79-85.
4. Zwierz K, Juszkiewicz J, Arciuch L, Gindziecski A. N-acetylo- Aheksozoaminidaza-enzym chorób Ty-Sachsa i Sandhoffa. Post Biochem 1992;38:127-32.
5. Zwierz K, Zalewska A, Zoch-Zwierz W. Izoenzymes of N-acetyl- Ahexosaminidase. Acta Biochim Pol 1999;46:739-51.
6. Rye CS, Withers SG. Glycosidase mechanisms. Curr Opin Chem Biol 2000;4:573-80.
7. Lerner UH. Transforming growth factor-A stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway. J Bone Miner Res 1996; 11:1628-39.
8. Faid V, Evjen G, Tollersrud OK, Michalski JC, Morelle W. Sitespecific glycosylation analysis of the bovine lysosomal alphamannosidase. Glycobiology 2006;16:440-61.
9. Perry W. Rifampicin, halothane and glucose as mediators of lysosomal enzyme release and tissue damage. Med Hypotheses 1988; 26:131-4.
10. Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2006;1:6-24.
11. Palva T, Makinen J. Histopathological observations on polyethylenetypematerials in chronic ear surgery. Acta Otolaryngol (Stockh) 1990; 109:124-9.
12. Olszewska E, Chodynicki S, Chyczewski L. Some markers of proliferative activity in cholesteatoma epithelium in adults. Eur Arch Otorhinolaryngol 2006;263:409-13.
13. Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257-65.
14. Cynamon U, Kronenberg J, Benayahu D. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma. Laryngoscope 2000;110:1198-203.
15. Zwierz K, Gicdziecski A, Ostrowska L, Stankiewicz-Choroszucha B. Metabolism of glycoconjugates in human gastric mucosa-a review. Acta Med Hung 1989;46:275-88.
16. Bazzi C, PetriniC, RizzaV, et al.UrinaryN-acetyl-A-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-6.
17. Liu J, Numa MM, Liu H, et al. Synthesis and high-throughput screening of N-acetyl-beta-hexosaminidase inhibitor libraries targeting osteoarthritis. J Org Chem 2004;69:6273-83.
18. Popko J, Zalewska A, Golaszewska Z, et al. Comparative analysis of hexosaminidase and cathepsin D expression in synovial fluid of patients with rheumatoid arthritis and traumatized joints. Clin Exp Rheumatol 2005;23(5):725-6.
19. Popko J, Zalewska A, Olszewski S, et al. Activity of N-acetyl- Ahexosaminidase in serum and joint fluid of knees of patients with juvenile idiopatic arthritis. Clin Exp Rheumatol 2003;21:675.
20. Olszewska E, Borzym-Kluczyk M, Olszewski S, Rogowski M, Zwierz K. Hexosaminidase as a new potential marker for middle ear cholesteatoma. Clin Biochem 2006;39:1088-90.
21. Ortutay Z, Polgar A, Gömör B, et al. Synovial fluid exoglycosidases are predictor of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion. Arthritis Rheum 2003;48:2163-72.
22. Wielgat P, Pancewicz S, Hermanowska-Szpakowicz T, et al. Aktywnov( egzoglikozydaz lizosomalnych w surowicy pacjentów z Boreliozowym przewlekaym zapaleniem stawów. Przegl Epidemiol 2004;58:451-58.
23. Popko J, Marciniak J, Zalewska A, et al. Activity of N-acetylo- betahexosaminidase and its izoensymes in serum and synovial fluid from patiens with different arthropaties. Clin Exp Rheumatol 2006; 24:690-3.
24. Olszewska E, Borzym-Kluczyk M, Olszewski S, Zwierz K. Catabolism of exoglycoconjugates in chronic otitis media with cholesteatoma. J Invest Med 2007;55:248-54.
25. Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngology Head Neck Surg 1995;112:359-68.
26. Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1996;253:152-7.
27. Scheller J, Ohnesorge N, Rose-John S. Interleukinn-6 (IL-6) transsignaling in chronic inflamation and cancer. Scand J Immunol 2006;63:321-9.
28. Chen CC, Wang SS, Lee FY, Chang FY, Lee SD. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-8.
29. Pihusch M, Pihusch R, Fraunberger P, et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogenic hematopoetic stern cell recipients. Eur J Haematol 2006;76:93-101.
30. Barone R, Carchon H, Jansen E, et al. Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency). J Inherit Metab Dis 1998;21:43-8.
31. Pezzilli R, Cappelletti O, Barakat B. Serum interleukin 6 in the prognosis of acute biliary pancreatitis. Ital J Gastroenterol Hapatol 1998;30:291-4.
32. Maegawa GHB, Tropak M, Buttner J, et al. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis. J Biol Chem 2007;282:9150-61.
33. Bygbejrg IC, Odum N, Theander TG. Effect of pyrimethamine and sulphadoxine on human lymphocyte proliferation. Trans R Soc Trop Med Hyg 1986;80:295-30.
34. Rutkowska J, Olszewska E, Waniewska E, et al. [Hexosoaminidase gene expression in cholesteatoma in adults]. Otolaryngol Pol 2009; 63:490-5.